Korea's GMP facility investment exceed 1.6 trillion won

Published: 2007-12-28 07:00:00

Updated: 2007-12-28 07:00:00

The nation's GMP (good manufacturing practice) facility spending surpassed 1.6 trillion in 2006 as part of part of efforts to survive in the era of free trade agreements (FTAs).

The Korea Pharmaceutical Manufacturers reported that 59 pharmaceutical firms plan to upgrade their GMP facilities wi...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK